A strong and present leadership is the anchor of our business..
Board of Directors
Therefore, we have carefully composed a solid board of directors with highly qualified directors each offering relevant knowledge to our business.
Christian Vinding - Board Director
MORE
Has 20+ years of experience and is specialised within Regulatory Life Science, Healthcare, M&A and Corporate Law
Christian is also highly specialised in legal issues facing the pharmaceutical industry, and has represented multiple companies in issues such as GCP, GMP, GDP, Market Access and Marketing Compliane
Team leader in multiple large succesful transactions including listings and mergers within the pharmaceutical industry.
Lars Gundorph, Board Member
MORE
Has worked with sales and risk management for several years and has successfully started several companies.
In 2021, he was the mastermind behind the new advisory house, North Risk, which consists of the companies Contea (Risk management & insurance), Jysk
Pension (Health and pension), status (Mortgage afvice) and FinPro (Financial Procurement). North has since 2021 acquired more companies and has app. 170 employees.
He has been a member of several boards since 2004. Lars is currently chairman of the board of K/S City Hotels, which he has done since 2008. Previously, Lars has served on the board of Wilis Towers Watson, Sam Headhunting Group A/S and Falck Healthcare A/S, among others.
Omar S. Qandeel - Board Member
MORE
Mr. Qandeel subsequently developed his relationship with Japanese companies including ShinMaywa Industries Ltd., FUJIFILM Corporation, Kawasaki and Global Mobility Service Inc., among others, in the roles of consultant and advisor. Mr. Qandeel’s passion for education has led him to gain various positions in educational institutions. He has been appointed as a member of the Perlmutter Institute Global Executive Council of Brandeis International Business School in the USA. He is a vice-chairman of the international advisory board of the Universidad Camilo Jose Cela in Spain. He is an advisor of Fujita Health University in Japan. Lastly, he is a chairman of the advisory board of the Arrowsmith Program in Canada, and investor in the European license of the program.
Mr. Qandeel has a very extensive international network, both clinically and in relation to potential strong strategic alliances and new investors. If elected, he expects to focus on securing funding from investors and to support the Company’s commercial expansion into new markets including the Middle East and Asia.
In summary of the above, Omar S. Qandeel holds the following management/advisory positions (as of today):
- Member of the advisory board of Jose Camellia University
- Member of the advisory board of Fujita Medical University
- Advisor to the board of Kawasaki
- Advisor to the board of Shinmaywa Industries